Preventing and managing bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation

References

• Chien JW, Duncan S, Williams KM, Pavletic SZ. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation – an increasingly recognized manifestation of chronic graft-versus-host disease. Biol. Blood Marrow Transplant.16(1 Suppl.), S106–S114 (2010).
   PubMedGoogle Scholar
• Trulock EP, Christie JD, Edwards LB et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart–lung transplantation report – 2007. J. Heart Lung Transplant.26(8), 782–795 (2007).
   PubMed Web of Science ®Google Scholar
• Santo Tomas LH, Loberiza FR Jr, Klein JP et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest128(1), 153–161 (2005).
   PubMed Web of Science ®Google Scholar
• Friedrichs B, Tichelli A, Bacigalupo A et al. Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial. Lancet Oncol.11(4), 331–338 (2010).
   Google Scholar
• Patriarca F, Skert C, Sperotto A et al. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant.33(7), 751–758 (2004).
   Google Scholar
• Sharma S, Nadrous HF, Peters SG et al. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest128(3), 1385–1392 (2005).
   PubMed Web of Science ®Google Scholar
• Marras TK, Chan CK, Lipton JH, Messner HA, Szalai JP, Laupacis A. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant.33(5), 509–517 (2004).
   Google Scholar
• Filipovich AH, Weisdorf D, Pavletic S et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol. Blood Marrow Transplant.11(12), 945–956 (2005).
   PubMed Web of Science ®Google Scholar
• Au BKC, Au MA, Chien JW. Bronchiolitis obliterans syndrome following allogeneic hematopoietic cell transplantation: prevalence, risk factors, and outcomes according to the National Institutes of Health consensus criteria. Biol. Blood Marrow Transplant. (2011) (In Press).
   Google Scholar
• Stein-Streilein J, Lipscomb MF, Hart DA, Darden A. Graft-versus-host reaction in the lung. Transplantation32(1), 38–44 (1981).
   PubMed Web of Science ®Google Scholar
• Epler GR, Colby TV. The spectrum of bronchiolitis obliterans. Chest83(2), 161–162 (1983).
   PubMed Web of Science ®Google Scholar
• Clark JG, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann. Intern. Med.107(5), 648–656 (1987).
   PubMed Web of Science ®Google Scholar
• Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol. Blood Marrow Transplant.9(10), 657–666 (2003).
   PubMed Web of Science ®Google Scholar
• Chalermskulrat W, Neuringer IP, Brickey WJ et al. Hierarchical contributions of allorecognition pathways in chronic lung rejection. Am. J. Respir. Crit. Care Med.167(7), 999–1007 (2003).
   Google Scholar
• Richards DM, Dalheimer SL, Ehst BD et al. Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease. J. Immunol.172(6), 3469–3479 (2004).
   Google Scholar
• Duncan SR, Capetanakis NG, Lawson BR, Theofilopoulos AN. Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival. J. Clin. Invest.109(6), 755–764 (2002).
   PubMedGoogle Scholar
• Kelly KE, Hertz MI, Mueller DL. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas. Transplantation66(6), 764–771 (1998).
   Google Scholar
• Neuringer IP, Mannon RB, Coffman TM et al. Immune cells in a mouse airway model of obliterative bronchiolitis. Am. J. Respir. Cell. Mol. Biol.19(3), 379–386 (1998).
   PubMedGoogle Scholar
• Chien JW, Zhao LP, Hansen JA, Fan WH, Parimon T, Clark JG. Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation. Blood107(5), 2200–2207 (2006).
   PubMed Web of Science ®Google Scholar
• Hildebrandt GC, Granell M, Urbano-Ispizua A et al. Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant.14(1), 67–74 (2008).
   Google Scholar
• Erard V, Chien JW, Kim HW et al. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J. Infect. Dis.193(12), 1619–1625 (2006).
   PubMed Web of Science ®Google Scholar
• Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann. Intern. Med.111(5), 368–376 (1989).
   PubMed Web of Science ®Google Scholar
• Curtis DJ, Smale A, Thien F, Schwarer AP, Szer J. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant.16(1), 169–173 (1995).
   PubMed Web of Science ®Google Scholar
• Chan CK, Hyland RH, Hutcheon MA et al. Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore)66(5), 327–340 (1987).
   Google Scholar
• Markopoulo KD, Cool CD, Elliot TL et al. Obliterative bronchiolitis: varying presentations and clinicopathological correlation. Eur. Respir. J.19(1), 20–30 (2002).
   PubMed Web of Science ®Google Scholar
• Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J, Cordier JF. Post-transplant obstructive lung disease (“bronchiolitis obliterans”): a clinical comparative study of bone marrow and lung transplant patients. Eur. Respir. J.8(4), 551–558 (1995).
   PubMed Web of Science ®Google Scholar
• Yokoi T, Hirabayashi N, Ito M et al. Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases. Nagoya BMT Group. Virchows Arch.431(4), 275–282 (1997).
   PubMed Web of Science ®Google Scholar
• Yoshihara S, Yanik G, Cooke KR, Mineishi S. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant.13(7), 749–759 (2007).
   PubMed Web of Science ®Google Scholar
• Williams KM, Chien JW, Gladwin MT, Pavletic SZ. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA302(3), 306–314 (2009).
   PubMed Web of Science ®Google Scholar
• Gunn ML, Godwin JD, Kanne JP, Flowers ME, Chien JW. High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J. Thorac. Imaging23(4), 244–250 (2008).
   PubMed Web of Science ®Google Scholar
• Ooi GC, Peh WC, Ip M. High-resolution computed tomography of bronchiolitis obliterans syndrome after bone marrow transplantation. Respiration65(3), 187–191 (1998).
   PubMed Web of Science ®Google Scholar
• Ratjen F, Rjabko O, Kremens B. High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplant.36(2), 135–138 (2005).
   PubMed Web of Science ®Google Scholar
• Smith EP, Sniecinski I, Dagis AC et al. Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease. Biol. Blood Marrow Transplant.4(1), 27–37 (1998).
   Google Scholar
• Besnier DP, Chabannes D, Mahe B et al. Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study. Transplantation64(1), 49–54 (1997).
   PubMed Web of Science ®Google Scholar
• Ilhan O, Arat M, Arslan O et al. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease. Transfus Apher. Sci.30(3), 185–187 (2004).
   PubMed Web of Science ®Google Scholar
• Lucid CE, Savani BN, Engelhardt BG et al. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant. DOI: 10.1038/bmt.2010.152 (2010) (Epub ahead of print).
   Google Scholar
• Fullmer JJ, Fan LL, Dishop MK, Rodgers C, Krance R. Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-α blockade. Pediatrics116(3), 767–770 (2005).
   PubMed Web of Science ®Google Scholar
• Majhail NS, Schiffer CA, Weisdorf DJ. Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transplant.12(7), 789–791 (2006).
   PubMed Web of Science ®Google Scholar
• Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr. Pract.15(5), 469–474 (2009).
   PubMed Web of Science ®Google Scholar
• McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr. Opin. Rheumatol.20(2), 131–137 (2008).
   PubMed Web of Science ®Google Scholar
• Norman BC, Jacobsohn D, Williams KM et al. Fluticasone, azithromycin, and monteleukast (FAM) therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant. (2011) (In Press).
   Google Scholar
• Bashoura L, Gupta S, Jain A et al. Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transplant.41(1), 63–67 (2008).
   PubMed Web of Science ®Google Scholar
• Bergeron A, Belle A, Chevret S et al. Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplant.39(9), 547–553 (2007).
   PubMed Web of Science ®Google Scholar
• Khalid M, Al Saghir A, Saleemi S et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur. Respir. J.25(3), 490–493 (2005).
   PubMed Web of Science ®Google Scholar
• Medoff BD, Seung E, Wain JC et al. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J. Exp. Med.202(1), 97–110 (2005).
   Google Scholar
• Wilborn J, Bailie M, Coffey M, Burdick M, Strieter R, Peters-Golden M. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J. Clin. Invest.97(8), 1827–1836 (1996).
   PubMed Web of Science ®Google Scholar
• Or R, Gesundheit B, Resnick I et al. Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study. Transplantation83(5), 577–581 (2007).
   PubMed Web of Science ®Google Scholar
• Sano Y, Date H, Nagahiro I, Aoe M, Shimizu N. Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation. Ann. Thorac. Surg.79(3), 1051–1052 (2005).
   PubMedGoogle Scholar
• Okumura H, Ohtake S, Ontachi Y et al. Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs? Int. J. Hematol.86(4), 369–373 (2007).
   Google Scholar
• Rabitsch W, Deviatko E, Keil F et al. Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation. Transplantation71(9), 1341–1343 (2001).
   PubMed Web of Science ®Google Scholar
• Calhoon JH, Levine S, Anzueto A, Bryan CL, Trinkle JK. Lung transplantation in a patient with a prior bone marrow transplant. Chest102(3), 948 (1992).
   Google Scholar
• Christie JD, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report – 2010. J. Heart Lung Transplant.29(10), 1104–1118 (2010).
   PubMed Web of Science ®Google Scholar
• Couriel D, Carpenter PA, Cutler C et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol. Blood Marrow Transplant.12(4), 375–396 (2006).
   PubMed Web of Science ®Google Scholar
• Chien JW, Martin PJ, Gooley TA et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am. J. Respir. Crit. Care Med.168(2), 208–214 (2003).
   PubMed Web of Science ®Google Scholar
• Walter EC, Orozco-Levi M, Ramirez-Sarmiento A et al. Lung function and long-term complications after allogeneic hematopoietic cell transplant. Biol. Blood Marrow Transplant.16(1), 53–61 (2010).
   Google Scholar